Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CME GroupMIL:1CME 66 Cyclically Adjusted PS Ratio is 14.72 as of Jul. 20, 2026, which is 6% below its 10-year median of 15.62. GuruFocus rates MIL:1CME with a GF Score™ of 66/100 and a GF Value™ of €238.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 606 Capital Markets companies, CME Group ranks worse than 87.62% on this metric.
The historical rank and industry rank for CME Group's Cyclically Adjusted PS Ratio or its related term are showing as below:
MIL:1CME'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 10.42 Med: 15.62 Max: 20.54
Current: 14.73
During the past years, CME Group's highest Cyclically Adjusted PS Ratio was 20.54. The lowest was 10.42. And the median was 15.62.
MIL:1CME's Cyclically Adjusted PS Ratio is ranked worse than 87.62% of 606
companies
in the Capital Markets industry
Industry Median: 3.32
vs MIL:1CME: 14.73
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
CME Group's adjusted revenue per share data for the three months ended in Mar. 2026 was €4.478. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €14.58 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
CME Group (MIL:1CME) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
CME Group Cyclically Adjusted PS Ratio Related Terms
CME Group Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for CME Group's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1CME vs MCO, ICE, NDAQ: Cyclically Adjusted PS Ratio Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Cyclically Adjusted PS Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where CME Group's Cyclically Adjusted PS Ratio falls into.
CME Group Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
CME Group's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 14.72 mean?
CME Group (MIL:1CME) has a Cyclically Adjusted PS Ratio of 14.72 as of Jul. 20, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on CME Group and its competitors. This is near median its historical median of 15.62. Over the past decade, CME Group's Cyclically Adjusted PS Ratio has ranged from 10.42 to 20.54. According to the industry distribution chart, CME Group ranks #531 out of 606 companies in the Capital Markets industry, placing it in the top 87.6%.
Is CME Group's Cyclically Adjusted PS Ratio too high?
CME Group's current Cyclically Adjusted PS Ratio of 14.72 is near median its 10-year median of 15.62. Over the past 10 years, this metric has ranged from a low of 10.42 to a high of 20.54. The Capital Markets industry median Cyclically Adjusted PS Ratio is 3.32. CME Group's value of 14.72 is 343.4% above this industry median. Based on the distribution chart, CME Group ranks #531 out of 606 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, CME Group has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Cyclically Adjusted PS Ratio compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #531 out of 606 companies for Cyclically Adjusted PS Ratio. This places CME Group in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 3.32. CME Group's value of 14.72 is 343.4% above this benchmark. Historically, CME Group's own Cyclically Adjusted PS Ratio has ranged from 10.42 to 20.54 over the past decade. While the company's 10-year median is 15.62 vs. the industry median of 3.32, CME Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Capital Markets company?
The median Cyclically Adjusted PS Ratio among Capital Markets companies is 3.32, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Cyclically Adjusted PS Ratio of 14.72 is 343.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Cyclically Adjusted PS Ratio is 3.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Cyclically Adjusted PS Ratio is 14.72, which is near median its own 10-year median of 15.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (MIL:1CME) is currently considered Modestly Undervalued. The stock's GF Value™ is €238.68, compared to a current price of €214.55 — trading 10.1% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 14.72, which is near median its 10-year median of 15.62 and 343.4% above the Capital Markets industry median of 3.32. CME Group's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For CME Group (MIL:1CME), the current Cyclically Adjusted PS Ratio is 14.72 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (MIL:1CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of €214.55 is trading 10.1% below its estimated GF Value™ of €238.68.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for MIL:1CME:
Cyclically Adjusted PS Ratio: 14.72 (near median its 10-year median of 15.62)
GF Value™: €238.68 vs. price of €214.55 (10.1% below fair value)
Industry Position: 343.4% above the Capital Markets median (#531 of 606)
No single metric tells the full story. See the MIL:1CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
66GF Score
Get the complete analysis for MIL:1CME
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CME has been successfully added to your 
